Abstract
Midostaurin in Adults with Newly Diagnosed FLT3-Mutation-Positive Acute Myeloid Leukemia Eligible for Standard Chemotherapy: Update from the Radius-X Midostaurin Expanded Access Program
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have